Novartis Investigative Site

Taipei, Taiwan

0 studies enrolling now · 1 studies all time

What they study most

Acute Gout

Studies at this site

• Canakinumab in the Treatment of Acute Gout Flares and Prevention of New Flares in Patients Unable to Use Non-steroidal Anti-inflammatory Drugs (NSAIDs) and/or Colchicines Including a 12 Week Extension and a 1 Year Open-label Extension Study. — Completed